Seikagaku Corp

4548

Company Profile

  • Business description

    Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a main component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

  • Contact

    1-6-1 Marunouchi
    Chiyoda-ku
    Tokyo100-0005
    JPN

    T: +81 352208950

    http://www.seikagaku.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    1,260

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,416.6020.80-0.22%
CAC 408,714.9315.220.17%
DAX 4026,319.45179.320.69%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,901.0933.200.31%
HKSE25,824.44156.410.61%
NASDAQ26,690.62342.261.30%
Nikkei 22566,986.121,379.412.10%
NZX 50 Index13,853.4229.290.21%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,227.2022.40-0.24%
SSE Composite Index3,962.4422.400.57%

Market Movers